Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma

Clinical and Experimental Allergy

Volumn 33, Issue 1, 2003, Pages 78-83

  Karjalainen, Jussi ^a   Hulkkonen, J ^c   Nieminen, M M ^a   Huhtala, H ^d   Aromaa, A ^e   Klaukka, T ^f   Hurme, M ^b,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

Asthma; Eosinophil; Gene; IgE; IL 10; Lung function; Polymorphism

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GENDER; GENE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

AGED; ASTHMA; CASE-CONTROL STUDIES; EOSINOPHILS; FEMALE; HAPLOTYPES; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-10; LEUKOCYTE COUNT; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); SMOKING;

EID: 12244300909     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01577.x     Document Type: Article

References (33)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-45.
2. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54:825-57.
3. Pretolani M. Interleukin-10: An anti-inflammatory cytokine with therapeutic potential. Clin Exp Allergy 1999; 29:1164-71.
4. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
5. John M, Lim S, Seybold Jet al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
6. Magnan A, van Pee D, Bongrand P, Vervloet D. Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 1998; 53:1092-5.
7. Tillie-Leblond I, Pugin J, Marquette CH et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159:487-94.
8. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170-3.
9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1-8.
10. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42:1101-8.
11. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum 2001; 44:176-9.
12. Karjalainen A, Kurppa K, Martikainen R, Klaukka T, Karjalainen J. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 2001; 164:565-8.
13. Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Laboratory Invest Suppl 1982; 159:5-20.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16:1215.
15. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41:1090-5.
16. Edwards-Smith C J, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon-α. Hepatology 1999; 30:526-30.
17. Schneider S, Roessli D, Excoiffier L. Software for Population Genetics Data Analysis. Genetics and Biometry Laboratory, University of Geneva, Geneva, Switzerland, 2000.
18. Dupont WD, Plummer WD Jr. PS power and sample size program available for free on the internet. Control Clin Trials 1997; 18:274.
19. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998; 352:113.
20. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin-10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180:711-5.
21. Immervoll T, Loesgen S, Dutsch Get al. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat 2001; 18:327-36.
22. Burrows B., Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271-7.
23. Beeh KM, Ksoll M, Buhl R. Elevation of total serum immunoglobulin E is associated with asthma in non-allergic individuals. Eur Respir J 2000; 16:609-14.
24. Humbert M, Durham SR, Ying Set al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against 'intrinsic' asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154:1497-504.
25. Humbert M, Grant JA, Taborda-Barata Let al. High-affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and non-atopic asthma. Am J Respir Crit Care Med 1996; 153:1931-7.
26. Rabe KF. Mechanisms of immune sensitization of human bronchus. Am J Respir Crit Care Med 1998; 158:S161-70.
27. Busse WW. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma. Am J Respir Crit Care Med 2001; 164:S12-7.
28. Punnonen J, de Waal Malefyt R, van Vlasselaer P, Gauchat JF, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993; 151:1280-9.
29. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998; 160:3555-61.
30. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158:1958-62.
31. Makela M J, Kanehiro A, Borish Let al. IL-10 is necessary for the expression of airway hyper-responsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci USA 2000; 97:6007-12.
32. Joos L, Mclntyre L, Ruan Jet al. Association of lL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 2001; 56:863-6.
33. Karjalainen J, Hulkkonen J, Hurme M. IL-1 haplotypes and lung function decline. Thorax 2002; 57:561-2.